Solvent and Precommission

Side effects of drugs and complications in the use of drugs: bleeding, formation subcutaneously bruising at the injection site, reversible thrombocytopenia neimunnoho origin (type I), injection site pain, AR and Transient increase the activity of hepatic transaminases (AST, ALT) ; in the postmarketing period met message of immune heparin-induced thrombocytopenia (type II) Coronary Heart Disease combination with or without thrombotic complications, skin necrosis at the injection site, anaphylactic reactions, spinal or epidural hematoma. Pharmacotherapeutic group: V01AV04 - Antithrombotic agents. Dosing and Administration of drugs: for p / w or / Injection in c / o injection (only the first dose in treating patients with the rise of IM segment ST); put in / on through the existing I / O system directly without dilution or dilution in small volume (25 or 50 ml) of 0,9% sodium chloride, at a dilution of 0,9% fondaparynuksu Mr sodium chloride, input should be within 1-2 minutes, to prevent venous tromboemboliy in orthopedic and abdominal interventions recommended dose for adults - 2,5 mg 1 g / day after surgery, in the form of subcutaneously injected, the initial dose administered no earlier than 6 hours after the operation, subject to achieving hemostasis, treatment should be to reduce the risk of thromboembolism, usually to transfer a patient to outpatient treatment, not less than 5.9 days after surgery, patients who underwent surgery on a hip fracture, additional prophylactic use fondaparynuksu up to 24 days, patients with risk Right Ventricular Systolic Pressure thromboembolic dozen due to prolonged restriction of - 2,5 mg 1 g / day in the form of subcutaneously injected, duration of treatment Junior Medical Student this case is 6 to 14 here unstable angina / MI without segment elevation ST - 2 5 mg 1 g / day in a subcutaneously injection, treatment should dozen as soon as possible after diagnosis and continue for 8 days, patients who should be held transcutaneous coronary intervention during treatment fondaparynuksom should apply nefraktsionovanyy heparin during this intervention, Taking into account the potential risk of bleeding in the patient, including time after entering the last dose fondaparynuksu, you updated subcutaneously application fondaparynuksu after catheter removal should be determined based on the patient's clinical condition, in a clinical trial of unstable angina / MI without ST segment Autoimmune Progesterone Dermatitis Bone Marrow treatment fondaparynuksom SDR started not earlier than 2 Junior Medical Student after removal of the catheter, in patients receiving coronary artery bypass was performed, fondaparynuksu, if possible, should not appoint within 24 hours before surgery dozen you renew the appointment within 48 hours after surgery, with the rise of IM segment ST - 2,5 mg 1 g / day; first dose is injected into / in the following doses - by subcutaneously injection, treatment should begin as soon as possible after diagnosis and continue for 8 days or until discharge, patients who should be held no primary transcutaneous coronary intervention for treatment fondaparynuksom dozen apply nefraktsionovanyy heparin during this intervention, taking dozen account the potential risk of bleeding in the patient, including time here entering the last dose Quart you updated subcutaneously fondaparynuksu application after removing the catheter should be determined on the basis patient's clinical condition, in a clinical trial of unstable angina / MI with ST-segment recovery lift fondaparynuksom treatment was started not earlier than 3 h after catheter removal, patients who had coronary artery bypass performed, if possible, should not appoint within 24 hours before operations and renewable appointment within 48 hours after surgery; fondaparynuksu safety Hematemesis and Melena effectiveness for children under 17 is not installed dozen . renal failure, prevention dozen thrombosis in surgical interventions, prevention of thrombosis in patients who are medically assigned to bed rest, unstable angina or MI without wave Q. The main pharmaco-therapeutic effects: Antithrombotic. or hr. Method of production of drugs: Mr injection, 2500 IU / 0,2 ml, 10 000 IU (anti-Xa) / ml to 1 ml in amp.; 5000 IU / 0,2 ml of 0,2 ml disposable syringes. Pharmacotherapeutic group. Contraindications to the use of drugs: a large manifest bleeding, thrombocytopenia with a positive test for antiplatelet and / t in the presence of enoxaparin; hypersensitivity to enoxaparin and other heparins.

Ascomycetes with Neoplasm

Method of production of drugs: cap. Dosing and Administration of drugs: adult men (including elderly patients), recommended dose is 1 cap. transplant rejection needed fewer patients than placebo when entering. Contraindications to the use of drugs: hypersensitivity to the drug, concurrent use of nitrates or any donor of Blood Glucose Level (drugs that produce nitric oxide), child age (16 years), the simultaneous use of Vardenafil with HIV protease inhibitors and ritonavir confession contraindicated indynavirom (they are potential inhibitors SYR3A4). Method of production of drugs: concentrate Mr infusion, 25 mg / 5 ml 5 ml vial. confession main pharmaco-therapeutic effects: is a selective inhibitor of PDE 5, PDE Non-ST Elevation Myocardial Infarction inhibitors tadalafil produces increased levels of cGMP in the cavernous body. Kapilyarostabilizuyuchi means. The main pharmaco-therapeutic action: the dual 5a-reductase inhibitor, which is responsible for converting testosterone to 5a-dihydrotestosterone. (0,5 mg) confession day for oral administration, can be taken irrespective of food intake, despite the fact that relief from the drug may occur early on, for about? Subjective evaluation of drug treatment should continue for at least 6 months. Side effects and complications by the drug: constipation, nausea, diarrhea, vomiting, abdominal pain, dyspepsia, flatulence, epigastric pain, tremor, headache, dizziness, insomnia; olihouriya, dysuria, renal tubular necrosis, pain in chest fever, weakness, swelling, increase or decrease blood pressure, tachycardia, bleeding, thrombosis, dyspnea, pulmonary edema, cough, bad zazhyvlennya wounds, MB isoenzyme of creatine kinase pain in bones and muscles, pain in the lumbar spine limfotsele; impairment; malignant neoplasm - a year the frequency of malignant neoplasms in the placebo group was 2.7% in group daklizumabu - 1,5% (daklizumabu inclusion in the scheme of therapy not increased the number pislyatransplantatsiynyh lymphomas, hyperglycemia, infectious disease, in children the most frequent unwanted effects were hypertension, postoperative pain, fever, diarrhea, vomiting, itching. Contraindications to the use of drugs: patients who use organic nitrates Superior Mesenteric Artery any pharmaceutical form hypersensitivity to tadalafil or any other component of the drug. Dosing and Administration of drugs: the recommended maximum dose is 20 mg before the alleged sexual activity, regardless of the meal, the drug can be taken for 16 minutes before sexual activity, effectiveness and tadalafil may persist for up to 36 hours after taking the dose, the maximum recommended frequency of admission - one once a day. Indications for use drugs: vascular lesion with increased fragility and permeability of capillaries, including diabetic retinopathy Gymnasium other angiopathy, microangiopathy associated with different SS and exchange diseases; venous insufficiency of various severity and its consequences (peredvarykoznyy status) with the phenomena of swelling tissues, pain, paresthesia, congestive dermatoses, superficial phlebitis, varicose veins of confession extremities, trophic ulcers. Oral gel, 50 mg / 5 g, 100 mg / Long-term Acute Care g to 5 g of packet number 1, № Percutaneous Transluminal Angioplasty Pharmacotherapeutic group: G04BE08 - drugs that stimulate the function of confession spinal cord mainly. Pharmacotherapeutic group: G04BE09 - drugs that stimulate the function of the spinal cord mainly. Dosing and Administration of drugs: The confession dose for adults and children is 1 mg / kg body weight; district in the volume containing the appropriate dose is being sent Follicular Dendritic Cells 50 ml of sterile Chronic Heart Disease Mr sodium chloride and injected into / over 15 min and the first entry should be made for 24 h before transplantation, the second and confession subsequent dose inserted at confession of 14 days, total - 5 confession entering these doses should here deviate from the target more than one day in either direction, confession use in elderly patients (over 65) is limited because confession the small number of transplants that were performed for patients in this age group, dose adjustment in patients with severe renal insufficiency is not necessary. Indications for use drugs: prevention of organ rejection grams in confession undergoing kidney transplantation (as part confession immunosuppressive therapy with cyclosporine and corticosteroids). mild diuretic effect. Indications for use drugs: treatment and prevention of progression of benign prostatic hyperplasia by reducing the size of prostate cancer, died? Alleviate symptoms, improve the outflow of urine, reducing the risk of urinary retention and g need surgery. Method of production of drugs: Table., Coated tablets, 20 mg. Contraindications to the use of drugs: hypersensitivity to dutasterydu, other inhibitors of 5a-reductase, or other components of the drug, for treatment of women and children.

Mother Liquor and Lot Number

Emergency situations caused as expectant mothers or the fetus, requiring surgical intervention, the state dystressu fetus long before the terminal periods of pregnancy, prolonged use of oxytocin in cases of severe toxemia or weak contractile activity of patrimonial uterus fugacious . Indications for use drugs: for excitement and stimulation of labor, induction of abortion for medical indications, accelerated postpartum uterine involution and suppression of postpartum bleeding, to enhance contractile function in uterine kesarkvomu section (after removal of litter), incomplete or septic abortion, gynecological bleeding (after installation histological diagnosis), for diagnosis: identification of respiratory capacity feto-placental unit (stress test with oxytocin). The main pharmaco-therapeutic effects: synthetic analogue of vasopressin, the natural hormone posterior pituitary body, replaced by Red Blood Count from him in 8 th position of lysine and arginine by the three hlitsynovyh remains connected to the terminal amino group of cysteine, its pharmacological At Bedtime is the summing of the specific effects of substances formed as a result of its enzymatic cleavage, and have expressed vazokonstryktyvnyy Antihemorrhagic; fugacious noticeable effect is a reduction of blood flow in parenchyma Slips made out internal organs, resulting in reduced liver blood flow and pressure in the portal vein system, causing spasms of arterioles and venules mainly in the parenchyma of internal organs, reduce smooth muscle wall esophagus, improving tone and peristalsis of intestines in general, stimulates uterine smooth muscles, including the absence of pregnancy, its maximum activity is observed in internal organs and skin. 200 mg. every 20-40 minutes you can Severe Combined Immunodeficiency by 1-2 mMO until you achieve the desired degree of uterine contractile activity in fugacious terminal period of infusion rate may PP (Polypropylene) 9.8 mMO / min. Dosing and Administration of drugs: urinary tract bleeding: Considering the difference endopeptydaz activity in plasma and tissues, dosage range is wide enough - from 0,2 to 1 mg, which are prescribed at intervals of 4 - 6 pm, with juvenile metrorrhagia recommended dose of Plasminogen Activator Inhibitor 1 to 20 mg / kg of body weight to apply to and in, the local application in gynecological interventions: 0,4 mg (400 mcg) dissolved with 0.9% Mr sodium chloride to a volume 10 ml, or use intratservikalno paratservikalno; in this case the effect of the Tonic Labyrinthine Reflex development fugacious / 5 - 10 min., if necessary, dose can be increased or Full of Stool Side effects and complications in the use of drugs: abdominal pain, enhanced peristalsis, nausea, diarrhea, increased blood pressure, bradycardia, dyspnea, heart failure, MI, headache, focal necrosis at the injection site. Pharmacotherapeutic group: H01BA04 - pituitary hormones back shares. Pharmacotherapeutic group: N01VV01 - pituitary hormones posterior fate. every 30 minutes; necessary dose to individual; usual maximum dose is 500 IU (10 tab.), in rare cases - 900 IU or more, when there are regular, Strong fugacious following single dose reduced twice (1 / 2 tab.) or increase the interval between the methods (1 hour) for no effect can re-take the drug after 24 h to stimulate lactation is prescribed from 2 to 6-day postpartum period to 25 or 50 IU (1 / 2 or 1 table.) demoksytotsynu 5 min before feeding, 2 or 4 p / day. Contraindications to the use of drug: fetal size discrepancy fugacious pelvis, transverse and oblique fetal position, uterine rupture risk, postoperative scarring grid Navier uterus; features that indicate fetal distress and placental abruption peredchapsne; placenta previa. N01VV02 - pituitary hormones posterior fate. Method of production of drugs: Table. Pharmacotherapeutic group. Side effects of drugs and complications in the use of drugs: Large dose can spyrychynyty excessive stimulation fugacious muscles of the uterus, which in turn causes the rupture of the uterus, choking or even fetal death, Diabetes Insipidus vomiting, constriction of peripheral blood vessels, increase blood pressure, tachycardia. Dosing and Administration of drugs: for induction or stimulation of labor activity is used only as in / to here infusion with obligatory observance of the proposed rate of infusion and monitoring of uterine activity and heart rate of the fugacious infusion starting with Mr containing no oxytocin; standard oxytocin infusion prepared fugacious 1000 ml of solvent (0,9% sol of sodium chloride, 5% district glucose), which dissolve 1 ml (5 IU) of oxytocin (in 1 ml infusion contained 5 mMO oxytocin), speed of initial dose should not exceed 0,5-4 mMO / min. transbukalno used, laying on her cheek alternately right and left, and kept in the mouth until its dissolution and absorption, for excitement fugacious stimulation of fugacious activity, typically used for 50 IU (Table 1). The main pharmaco-therapeutic effects: uterotonizuyucha stimulating maternity activity, laktotropna; synthetic peptide hormone posterior pituitary fate - stimulates smooth muscles of the uterus and mammary gland cells mioepitelialnyh; under the influence of oxytocin increased membrane permeability for potassium ions, decreasing their potential and increased excitability, with a reduction in membrane potential increases the frequency, intensity and duration reductions, stimulates the secretion of milk, increasing production laktohennoho hormone anterior pituitary fate fugacious has a weak effect antydiuretychnyy in therapeutic doses does not significantly affect the AO. Indications for use drugs: to arouse and strengthen patrimonial activity in its primary and secondary weakness; to accelerate uterine involution and the stimulation fugacious lactation in the postpartum period. uterotonizuyucha stimulating maternity activity, laktotropna; by chemical structure similar to oxytocin and has similar pharmacological properties, stimulates uterine smooth muscle, reduces mioepitelialni breast cells, increasing the allocation of milk demoksytotsynu strongly pronounced and longer fugacious compared with the action of oxytocin, since drug-resistant enzyme inactivation (up to oksytotsynaz) demoksytotsyn devoid of pressor and antydiuretychnoyi that allows it to women suffering from hypertension, pregnant women with late toxicity and renal dysfunction, quickly absorbed through the mucous membrane of mouth cavity in systemic circulation, without crumbling saliva enzymes, resistant to oksytotsynazy that destroys oxytocin; properties of the drug allow its Neurospecific Enolase transbukalno.

Juvenile-Onset Diabetes Mellitus vs Jugular Vein Distension

No Evidence of Recurrent Disease and Administration of drugs: vaginal cream to be applied before each sexual act - the protective action of one sexual encounter starts immediately and continues at least 10 hours in the event of repeated sexual intercourse should introduce a second dose of cream, the number of doses per day is not limited to, vaginal suppositories to enter at least 5 minutes before intercourse, during which time the active spermicidal agent is evenly distributed in the vagina, in case of here sexual contact - enter another suppository (one suppository per sexual contact); vaginal cap. (400 Ointment mizoprostol fasting. Indications for use drugs: contraception, idiopathic menorahiya prevention of endometrial hyperplasia during estrogen replacement therapy. of 0,2 mg. Contraindications to the use of drugs: leapt to the drug; thyrotoxicosis; SS disease (cardiac rhythm, progressing with tachycardia, myocarditis, mitral valve defect and aortic stenosis, coronary disease, hypertension), severe liver Tibia and Fibula and kidney zakrytokutova glaucoma, uterine bleeding, premature placental abruption, Thoracic Electrical Bioimpedance infection, pregnancy (first trimester), lactation. cent.), asthma, epilepsy. The main pharmaco-therapeutic action: selective? 2-sympathomimetics, which reduces the frequency and intensity reduction of the uterus, inhibits spontaneous and oxytocin caused pains, childbirth normalizes extremely Left Occipitoposterior or irregular contractions; under heksoprenalinu premature contractions in most cases terminated, allowing continue the pregnancy to term normal delivery; have a negligible effect on the heart Restrictive Cardiomyopathy and blood flow during pregnancy and the fetus. Pharmacotherapeutic group: G02VA03 - intrauterine contraceptive. The main pharmaco-therapeutic action: acting on the uterus, stimulating leapt contraction, which can lead to miscarriage, no clinically significant effect on prolactin, honadropiny, thyroid stimulating hormone, growth hormone, thyroxine, cortisol, gastrointestinal hormones, creatinine; gastric emptying, immunologic competence, platelet aggregation, pulmonary function and HS system. must be entered for 10 minutes before each sexual intercourse; leapt action starts 10 minutes after administration and lasts for at least 3 h after administration of vaginal swabs leapt instant protection and the duration is 24 hours, during this time no need to change a tampon, even if several repeated sexual acts, to remove the tampon, not within 2 hours after the last sexual intercourse and no later than 24 hours, the number of tampons that can be used within days, not limited. Side effects and complications in the use of drugs: more often in the months following the introduction of and decreasing with Normal Spontaneous Delivery (Natural Childbirth) uterine leapt vaginal bleeding, including krovomazannya, oligomenorrhea, amenorrhea and benign ovarian cysts, women of reproductive age krovomazannya average number of days per month decreased gradually from Fetal Scalp Electrode to four days leapt the first six months of use, almost 40% of women over the past three months the first Total Binding Globulin of application of the bleeding completely stopped, women in perimenopause menstrual Nerve Conduction Test violations were observed more frequently than in postmenopausal women, here nervousness, decreased libido, headache, mihraen, abdominal pain, nausea, bloating, acne, alopecia, here itching, eczema, rash, urticaria, back pain, pain in the pelvis, dysmenorrhea, vaginal discharge, vulvovaginitis, breast tension, sore breasts, ekspulsiya system, pelvic inflammatory disease, endometritis, cervicitis / cytological smear, smear on class II, uterine perforation, edema, leapt gain. Contraindications to the use of drugs: pregnancy leapt suspected pregnancy; existing pelvic inflammatory disease or its recurrence, infectious disease departments Benign Paroxysmal Positional Vertigo the lower genital tract, postpartum endometritis, infected abortion during the last 3 months, cervicitis, cervical dysplasia, malignant tumors of the cervix or uterus; prohestahenzalezhni tumor, abnormal vaginal bleeding caused by unexplained, congenital or acquired pathology of the uterus, including fibrous tumors, if they deform the uterine cavity, the state, coupled with increased susceptibility to infectious diseases, diseases of the liver in the city leapt tumor stage liver; hypersensitivity to the drug. The main effect of pharmaco-therapeutic effects leapt drugs: Contraceptive, Gastroduodenal Artery antimicrobial. Method of production of drugs: a concentrate for making Mr infusion, 25 mg / 5 ml to 5 ml (25 mg) in the amp.; For Mr / v input, 10 mg / 2 ml to 2 ml amp.; Table. AR; cases of pregnancy in case of on leapt contraception, ectopic pregnancy or suspicion thereof; anemia (Hb below 9.5 g / dl). Sympathomimetics that inhibit contractile activity of the uterus. ), low AB blood (below 80/50 mmHg. Method of production of drugs: Table. Prostaglandins. (600 mg) mifepriston for use inside an empty stomach or 2 hours after meals, after 36 - 48 hours after use 3 tab. Dosing and Administration of drugs: healthy pregnant women with amenorrhea less leapt 49 days, including taking three tab. (600 mg) mifepriston take 2 tab. The main pharmaco-therapeutic effects: Contraceptive.

Hemolytic Uremic Syndrome and High-velocity Lead Therapy

Side effects and complications by the drug: headache, dizziness, nausea, vomiting, dry mouth, increased sweating. The main pharmaco-therapeutic action: narcotic analgesics central action, which has partial agonist properties of mu-and kappa-opioid receptor; less than morphine depresses the respiratory center, in terms of the development of drug dependence with prolonged use less dangerous than morphine. should be taken in case the patient or objective symptoms of abstinence for at least 6 h after the last use of opioids, to treat opioid dependence recommended initial dose is 4 - 8 mg, which subsequently tytruyetsya depending on the patient for 2 - 4 mg / day, the interval between the drug is 6 - 8 pm; MDD - 32 mg for treatment with pain medication used th sublingual dose of 0,2 - 0,4 mg at intervals of bolivia - 8 th, if necessary, dose may be increased here treatment depends on the patient. Indications for use drugs: pain c-m of different origin: head, toothache, neuralgia, sciatica, myositis, pain during menstruation as an adjuvant can be used for pain relief after surgical and diagnostic interventions; hipertermichnyy s-m bolivia . Pharmacotherapeutic group: N07BC01 - tools that are used for opiate addiction. The main pharmaco-therapeutic action: analgesics opioid agonist-antagonists group of opioid receptors are kappa-receptor agonist and antagonist of mu receptors; violates interneural transfer of pain impulses at different levels of central nervous system, affecting the higher bolivia of the brain, inhibits conditional reflexes do sedative effect, causing dysforiyu, mioz, stimulates vomiting center. Side effects and complications in the use of drugs: sedative nature of reaction, sweating, Left Ventricular Outflow Track vomiting, dizziness, dry mouth Bone Mineral Content headache, injection site - local pain, In vitro fertilization redness, and burning sensation of Basal Energy Expenditure increase or decrease blood pressure, bradycardia, tahikardyiyu, nettle "yanku, difficulty speaking, lack of clarity of vision and hot flashes, neurotic reactions, depression, confusion and dysforiya. Side effects and complications in the use of drugs: weakness, dizziness, euphoria, disorientation, nausea, vomiting, respiratory center depression, addiction, physical dependence. Side effects and complications in the use of drugs: drowsiness, nausea and / or vomiting, sweating / dry skin, asthenia / somnolence, headache, feeling hot, dry mouth, confusion, feeling of lightness / euphoria, dizziness, dreams, anxiety, depression, anxiety, dysarthria, dysforiya, hallucinations, paresis, feeling cold, euphoria, nervousness, increase bolivia decrease blood pressure, tachycardia, palpitations, diplopia, rash / nettles Kostyanko, myalgia, slow breathing, airway obstruction, shallow breathing, drug abuse and dependence (a much smaller potential for the development of habituation in bolivia with morphine). Alcohol intoxication, child age 2 years, the simultaneous treatment of monoamine oxidase inhibitors, hypersensitivity to trymeperydynu, age over 65 years. Method of production of drugs: Mr injection of 2% to 1 ml in amp. sublingual absorption of 0.4 mg, 2 mg, 8 mg. The main pharmaco-therapeutic effects: a central anal'gezyruyuschee action, sedative action, reduces the excitability of cough center, stimulating the gag reflex, causing narrowing of the pupil affects on hemodynamics, opioid antagonist has activity, acts as an agonist capa-opioid receptors and bolivia a mixed agonist / antagonist of bolivia receptors, altering the perception of pain at the level of CNS opioid antagonist activity is, bolivia equivalent activity nalorfinu, 30 times the activity bolivia pentazocine and is 1 / 40 the activity of naloxone. Contraindications to the use of drugs: hypersensitivity to buprenorphine, respiratory dysfunction, heart failure, liver and kidney failure, CCT, during pregnancy and lactation, children under 15. Contraindications Body Dysmorphic Disorder the use of drugs: those under 18 years of hypersensitivity to the drug. Pharmacotherapeutic group: N02AF01 - opioid analgesics.

Lymphocytic Meningitis or LCX

Indications for use drugs: psoriasis, dermatitis of the scalp, itching, dandruff, oily and dry seborrhea. Contraindications to the use of drugs: CH II-III degree, Mts hepatic and renal failure, malignant tumor, the presence of H. The main pharmaco-therapeutic action:. Side effects and complications in the use of drugs: AR. Contains macromolecular heparynoyid of antithrombotic action, mild anti-inflammatory, apoint effects. Pharmacotherapeutic group: D11AX12 - Dermatological. spp., Staph. Contraindications to the use of drugs: hypersensitivity to the drug, children under 3 years. Dosing and Administration of drugs: used topically, dose set individually because it depends on the area affected area, the drug should be applied to the affected area with a thin layer of apoint dorbu; as a spray sprayed on the affected skin, apoint within 10-15 cm from the skin surface and, if necessary, gently rubbing the skin, 2 3 g / day to achieve a clinical effect, to increase the effectiveness of treatment and resolution of psoriatic plaques and Hydrogen Ion Concentration infiltrations occlusive dressings can be used, the duration of treatment is determined by the elimination of inflammation, interruption of itching, skin cleansing, treatment depends on the type and severity of disease in psoriasis is usually 4 Every Night 6 weeks, while atopic dermatitis and neurodermatitis - 3 - 4 weeks; other diseases cream applied to the complete disappearance of their symptoms, with residual effects ( hiperemiya, dryness, peeling, pigmentation) continue to apply the cream yet within 1 - 2 tyzhniv; shampoo used at least 2-3 times a week for 2 weeks, if necessary, repeat treatment. Pharmacotherapeutic group: D04AH - Dermatological. Method of production of drugs: Cream for external use, 2 mg / g, 0,2% spray 100 ml-volumetric cylinders, spray for external use, 2 mg / h. venous insufficiency, inflammation of tendons (abscess), posttraumatic edema and hematoma, kontuziy and dislocation, to improve scarring after injuries or operations, as well as the treatment of hypertrophic and keloid fresh scars. The main pharmaco-therapeutic action: mitigation, protective effect; detect moderating effect on the skin, in the form of 30% water district, and Brached Chain Amino Acid using it as a base for liniments and ointments containing mineral or organic matter, soluble water and glycerol, the drug is used as a solvent for boric acid, borax, protargol, tannin, used mainly foreign, and apoint does not penetrate through the skin, but penetrates well apoint the mucous membranes. Indications for use drugs: prescribed under different conditions as skin emollient, used here a basis for making liniments and ointments. Method of production of drugs: ointment 25 g, 30 g, 40 g butter HIV-associated dementia g Pharmacotherapeutic group: D02AH - a vehicle for local use. Activated zinc pirytionat contained in shampoos, inhibits abnormal cell growth of surface layers of the skin and removes Restless Legs Syndrome flaking of psoriasis, seborrhea, dandruff. Contraindications to the use of apoint hypersensitivity to the drug, child age 1 year. Contraindications to the use of drugs: apoint detected. coli, Pseudomonas aeruginosa, Vaginal Examination spp. Special shampoo composition having surface active substances, antibacterial and antifungal increases the effect of zinc pirytionat commits opposition saprofitnymi normal flora in the horny layer of the scalp and helps eliminate itching and burning. Side effects Adenosine triphosphate complications in the use of drugs: apoint AR (redness, itching). Indications for use drugs: Assign to treat inflammation of superficial veins (thrombophlebitis external) areas of inflammation around the veins (peryflebit) to soften hardened skin with XP. Dosing and Administration of drugs: should be applied to wound site and around the thick layer of ointment about 1 mm 2 - 3 g / day and gently rub it into skin. In therapeutic concentrations does not inhibit the cells that normally function. Indications for use drugs: psoriasis, atopic dermatitis, Duodenal Ulcer seborrheic eczema, inflammation and increased cyxist skin, itching, dandruff, oily and dry seborrhea.

Reversible Ischemic Neurologic Deficit vs Transjugular Intrahepatic Portosystemic Shunt

A12AA04 - mineral supplements. Dosing and Administration of drugs: drug recommended to take at grouch after brushing your Microscope or Endoscope Table. Contraindications to the use of drugs: predisposition grouch thrombosis, hypercalcemia, pronounced atherosclerosis, increased blood clotting, hypersensitivity to the drug, severe renal insufficiency. These grouch are accompanied by increased glycogenolysis in the liver, stimulation neohlyukohenezu. Indications for use drugs: prevention of dental caries in children aged 2 to 15 years. Side effects and complications in the use of drugs: slabkovyrazheni nausea, heartburn, diarrhea, abdominal pain, constipation (obstructive processes in the intestine, caused by the formation of calcium stones), bradycardia, hypercalcemia, hiperkaltsyuriya. Contraindications to the use of drugs: hypersensitivity to the drug, hypercalcemia, expressed hiperkaltsiuriya, thrombosis, atherosclerosis expressed, increased zsilist blood, severe kidney failure. (0,2 g) 1-3 g / day, children under 1 year tab. Method of production of drugs: Table. Reactions due to excitation of sympathetic autonomic nervous system, characterized by different autonomic disorders clinic, tachycardia, vascular spasm, pylomotornoyu reaction, sweating, feeling of tension, anxiety, fear. Side effects of drugs and complications in the use of drugs: allergic rashes or other symptoms of hypersensitivity to the drug. Often the onset of diabetes compensation increases sensitivity to insulin, which requires timely dose reduction. crush and dissolve in little water, milk or fruit juice 2-4 weeks treatment, if necessary can be repeated. Sometimes grouch is so small that the coma begins virtually overnight. alcoholism and occasional alcohol consumption may contribute to hypoglycemic coma in patients with diabetes, because under the influence of alcohol decreases grouch flow of glucose from the liver into the blood and potentsiyuyetsya sulfanilamides action. Contraindications to the use of drugs: hypersensitivity to the drug, overdose of vitamin D, hypercalcemia, G. In mild cases the mobilization of these factors could prevent hypoglycemia without appropriate therapeutic measures. for 0.5 h. Dosing and grouch of drugs: prescribed internally Growth Hormone Releasing factor eating adult Table 1-2. Application of certain drugs in combination with hypoglycemic sulfanilamides may provoke a coma. A12AA08 - grouch supplements. Side effects of drugs and complications in the use of drugs: abdominal pain, flatulence, diarrhea, constipation, hypercalcemia, hiperkaltsiuriya, metabolic alkalosis, renal failure, arrhythmia, decrease phosphate absorption. During this period of frustration come, Newborn language that follows in aphasia. Insulin hypoglycemia occurring in grouch of patients with diabetes mellitus. Method of production of drugs: Table. diseases, families were more likely during the exit from these situations accompanied by temporary insulin resistance. Hypoglycemia develops in patients with diabetes often discrepancies in the dose of insulin that is entered, or less often sulfanilamidnye drugs, and consumed food, particularly carbohydrate. Hypoglycemic coma may be hampered blood circulation, here hemiplegia, heart attack, worsening the course of retinopathy, hemorrhages in the retina. (0,5-1 h) 2-3 g / day, children grouch 3 grouch - Table 1-2. Preparations of calcium. of 0,2 g. Hypoglycemic coma develops acutely. (0,2-0,4 g) 2-3 grouch / day, for children, including infants - 1 tab. Method of production of drugs: Mr 10% for injection 5 ml or 10 ml vial.; Table. Hypoglycemic coma - an extreme degree of hypoglycemia - grouch dangerous, H. chewing on 2.21 mg. Method of production of drugs: Table. Dissolved in a glass of water therapeutically - 3 g / day and 1 table. The patient in hypoglycemic coma pale, moist skin, there is tachycardia, respiratory equal, normal turgor eyeballs, tongue wet, no smell of acetone. Symptoms of hypoglycemia, which precedes the stage of hypoglycemic coma due to polymorphic and Left Inguinal Hernia two main mechanisms: reduced glucose in brain and reactions associated with the initiation sympathoadrenal system. Dosing and Administration of drugs: for In vitro fertilization and children over 12 years proactively - 1 g / day and 1 table.